Canadian Pharma, Biotech and Life Sciences Stocks

Is it too late to cash in on the pot stock boom?

As recreational pot becomes legal, it’s natural to think about investing in the cannabis industry. Some people have already gotten filthy rich trading in pot stocks, but you are late to the party. Have all the profits already been reaped or should you join in? Investment specialists say there is ...

Aphria is still a buy, GMP Securities says

Higher production costs are balanced with a brighter outlook for international sales for cannabis producer Aphria Inc. (Aphria Stock Quote, Chart: TSX:APH), says analyst Martin Landry of GMP Securities, who on Monday reiterated his “Buy” rating with the raised target price of $22.00 (was $15.00 ...

Online cannabis sellers bracing for major demand as legalization looms

TORONTO — As many as 100 locations across the country may be ready to sell cannabis on Wednesday when recreational pot is legalized across the country, but most Canadians’ first purchase of legal pot will likely be at the click of a button. Provincial and territorial governments and private ret ...

Tech Talk for Monday October 15th 2018

  WALL STREET RAW RADIO SATURDAY, OCTOBER 13, 2018: WITH YOUR HOST MARK LEIBOVIT AND GUESTS DON VIALOUX AND SINCLAIR NOE: https://tinyurl.com/yc3oqbvg   Excerpts from Don Vialoux’ comments on Wall Street Raw U.S equity markets took scary moves last week. The Dow Jones Industrial Average droppe ...

62 per cent of Americans now favor marijuana legalization, Pew study finds

With just one week to go until Canadians from coast to coast are free to light up legally, pot companies like Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart TSX:WEED, NYSE:CGC) and Aurora Cannabis (Aurora Cannabis Stock Quote, Chart TSX:ACB) are not only readying their weed supplies for ...

Constellation Brands stock won’t be saved by cannabis, this investor says

US-based Constellation Brands (Constellation Brands Stock Quote, Chart NYSE:STZ) made the investment deal heard ‘round the cannabis world this summer when it upped its stake in sector-leading Canopy Growth Corp (Canopy Growth Corp Stock Quote, Chart: TSX:WEED, NYSE:CGC), a move which triggered a ...

Organigram has 46 per cent upside, says Mackie Research

In a Thursday update to clients, Organigram Holdings (Organigram Holdings Stock Quote, Chart TSX:OGI) gets a price target raise from analyst Greg McLeish of Mackie Research Capital Corporation, who says the licensed cannabis producer is positioned to be a leader in both the medical and recreational ...

Get ready for carnage in the marijuana sector, this portfolio manager says

No space has been hotter this past month than the marijuana sector, with pot stocks continuing to race up (and sometimes down) the charts in the lead-up to recreational cannabis becoming a reality across Canada. And if you’ve been lucky enough to have placed some winning bets on stocks like Canop ...

Knight Therapeutics stock has 30 per cent upside, Mackie Research says

Specialty pharma company Knight Therapeutics (Knight Therapeutics Stock Quote, Chart TSX:GUD) has a new strategic partnership under its belt, the third of its kind this year alone, says Mackie Research’s André Uddin who in a client update on Tuesday maintained his “Buy” rating and $10.65 tar ...

Acasti Pharma stock has 1000% upside, Mackie Research says

Following pharmaceutical company Amarin’s positive cardiovascular results for its omega-3 fish oil capsules, Acasti Pharma (Acasti Pharma Stock Quote, Chart TSXV, NASDAQ:ACST) gets a big target raise from Mackie Research’s André Uddin. On Monday, the analyst reiterated his “Speculative Buy ...